REV Group's Q4 2025 results shine amid specialty vehicle sales, but valuation concerns suggest caution. Click here to read an ...

The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...

Membership-only discount retailer Costco (NASDAQ:COST) in Q4 CY2025, with sales up 8.3% year on year to $67.31 billion. Its ...

Negative 1%, showing a 13 percentage point year-over-year improvement and marking the best level as a public company. Annual ...

Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...

Extreme weather disasters fueled by climate change in Massachusetts have cost US taxpayers hundreds of millions of dollars.

The Employer Health and Benefits Strategy Survey 2026, outlines how 1,241 US employers are adjusting benefits strategies amid ...

How can CIOs safeguard operations, control costs and still lead large-scale investments that require deep organizational ...

Going into next year, 42% of employers cited health care cost control for both the organization and its employees as their No. 1 objective, moving last year’s top goal, “attracting and retaining a ...

When Mark Cuban talks about how his Cost Plus Drugs company can reduce prescription costs, his message is simple.